Semaglutide—the diabetes and weight-loss drug known by brand names like Ozempic and Wegovy—is continuing to show its potential to treat...
obesity
I run a medical practice built almost entirely around treating obesity by video. Labs, history, follow-up — all possible through...
As recently as the onset of COVID-19 four years ago, you probably didn’t know what a glucagon-like peptide 1 agonist,...
One of the persistent frustrations with GLP-1 weight loss drugs is the commitment they require. Weekly injections, strict maintenance dosing,...
For roughly 40% of American adults living with obesity, the medical playbook has barely changed in decades: Eat less, move...
Novo Nordisk President and CEO Mike Doustdar discusses the company's collaboration with artificial intelligence to accelerate drug discovery and development....
NFL legend and eMed Chief Wellness Officer Tom Brady and eMed CEO Linda Yaccarino discuss eMed's mission on 'The Claman...
Rapid weight‑loss drugs like GLP‑1s are changing lives — and health care — but there’s an often‑overlooked psychological cost. In...
Over 40 million Americans have reported using GLP-1 drugs for weight loss, a behavior reshaping everything from the healthcare industry...
Many Americans are long overdue for a good nap. Their health—and that of the economy—might depend on it. A rising...